Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Infinite Enzymes
AddedFeb 15, 2024
UpdatedJun 18, 2026
Infinite Enzymes

Infinite Enzymes

Series A

Infinite Enzymes: A Jonesboro-based science company innovating conversion technologies.

HQ
Jonesboro, AR, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Infinite Enzymes, founded in Jonesboro, Arkansas, is a pioneering science-based company focused on developing innovative technologies to enhance the conversion processes in various industries. Their core mission is to revolutionize protein production through next-generation plant biotechnology, specifically by utilizing corn as a medium for growing proteins and enzymes. The company's vision is to create a sustainable, scalable, and successful model for producing high-value proteins that can be applied across multiple sectors.

Notable figures affiliated with Infinite Enzymes include leading scientists and biotechnologists who have significantly contributed to the field. The company has secured patents for their corn-grown proteins and enzymes, marking a significant achievement in agricultural biotechnology. Their impact is evident in their ability to scale commercial production of these proteins, positioning them as a key player in the sustainable biotechnology market.

Infinite Enzymes - Similar Companies

GreenLab logo

GreenLab

greenlab.com

Elemental Enzymes logo

Elemental Enzymes

Novozymes logo

Novozymes

novozymes.com

Evozym Biologics logo

Evozym Biologics

EnzymeBioSystems logo

EnzymeBioSystems

Cell-Free Bioinnovations logo

Cell-Free Bioinnovations

cfb9.com

Future Fields logo

Future Fields

futurefields.io

Enzymatics logo

Enzymatics

Nitrogenics logo

Nitrogenics

Ventria Bioscience logo

Ventria Bioscience

Agrivida logo

Agrivida

agrivida.com

Codexis logo

Codexis

codexis.com

eXoZymes logo

eXoZymes

invizyne.com

Cascade Biocatalysts logo

Cascade Biocatalysts

PhylloTech logo

PhylloTech

Infinite Enzymes - Quick Facts

Who are Infinite Enzymes' competitors?

Companies similar to Infinite Enzymes include GreenLab, Elemental Enzymes, Novozymes and Evozym Biologics.

When was Infinite Enzymes founded?

Infinite Enzymes was founded in 2006.

Where is Infinite Enzymes' headquarters located?

Infinite Enzymes' headquarters is located in Jonesboro, AR, US.

When was Infinite Enzymes' last funding round?

Infinite Enzymes' most recent funding round was for $5.2M (USD) in April 2022.

How much has Infinite Enzymes raised to-date?

As of Apr 14, 2022, Infinite Enzymes has raised a total of $5.2M (USD).

How many employees does Infinite Enzymes have?

Infinite Enzymes has 6 employees as of Feb 5, 2024.

Infinite Enzymes - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Enzymes
  • Proteins
Tags
  • AgTech
  • Biotech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software